AUTL
Price
$3.11
Change
+$0.10 (+3.32%)
Updated
Nov 15, 03:09 PM (EDT)
116 days until earnings call
BBIO
Price
$23.60
Change
-$0.51 (-2.12%)
Updated
Nov 15, 03:12 PM (EDT)
97 days until earnings call
Ad is loading...

AUTL vs BBIO

Header iconAUTL vs BBIO Comparison
Open Charts AUTL vs BBIOBanner chart's image
Autolus Therapeutics
Price$3.11
Change+$0.10 (+3.32%)
Volume$3.87K
CapitalizationN/A
BridgeBio Pharma
Price$23.60
Change-$0.51 (-2.12%)
Volume$450
CapitalizationN/A
AUTL vs BBIO Comparison Chart
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AUTL vs. BBIO commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a StrongSell and BBIO is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (AUTL: $3.01 vs. BBIO: $24.11)
Brand notoriety: AUTL and BBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 182% vs. BBIO: 104%
Market capitalization -- AUTL: $800.94M vs. BBIO: $4.53B
AUTL [@Biotechnology] is valued at $800.94M. BBIO’s [@Biotechnology] market capitalization is $4.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 0 FA rating(s) are green whileBBIO’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 0 green, 5 red.
  • BBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both AUTL and BBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 5 TA indicator(s) are bullish while BBIO’s TA Score has 4 bullish TA indicator(s).

  • AUTL’s TA Score: 5 bullish, 5 bearish.
  • BBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AUTL and BBIO are a bad buy in the short-term.

Price Growth

AUTL (@Biotechnology) experienced а -25.50% price change this week, while BBIO (@Biotechnology) price change was -6.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

AUTL is expected to report earnings on Mar 11, 2025.

BBIO is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($4.53B) has a higher market cap than AUTL($801M). BBIO YTD gains are higher at: -40.277 vs. AUTL (-53.261).
AUTLBBIOAUTL / BBIO
Capitalization801M4.53B18%
EBITDAN/AN/A-
Gain YTD-53.261-40.277132%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLBBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
0%
Bullish Trend 8 days ago
0%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CABA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-8.51%
CABA - AUTL
36%
Loosely correlated
-5.74%
ACLX - AUTL
35%
Loosely correlated
-5.05%
BBIO - AUTL
32%
Poorly correlated
-2.74%
PLRX - AUTL
32%
Poorly correlated
-6.68%
LRMR - AUTL
32%
Poorly correlated
-4.66%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with BPMC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-2.74%
BPMC - BBIO
48%
Loosely correlated
-1.27%
ARGX - BBIO
46%
Loosely correlated
-0.72%
ALDX - BBIO
43%
Loosely correlated
-3.17%
TECH - BBIO
42%
Loosely correlated
-4.46%
RYTM - BBIO
42%
Loosely correlated
-0.50%
More